Abstract
The National Culture Collection of Pathogens (NCCP) is a microbial resource bank in Korea that collects pathogen resources causing infectious disease in human and distributes them for research and education. The NCCP bank attempts to discover strains with various characteristics and specific purposes to provide diverse resources to researchers. Staphylococcus aureus American Type Culture Collection (ATCC) 6538P is used as a reference strain in the microbial assay for antibiotics in the Korean and in the United States Pharmacopoeias. We aimed to analyze domestically isolated microbial resources from the NCCP to replace the S. aureus reference strain. Staphylococcus aureus strains were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and the VITEK-2 system and characterized by multilocus sequence typing, 16S rRNA sequencing, and antibiotic susceptibility testing. Several candidate strains had similar characteristics as the reference strain. Among them, the nucleotide sequence of the 16S rRNA region of NCCP 16830 was 100% identical to that of the reference strain; it was sensitive to six types of antibiotics and showed results most similar to the reference strain. A validity evaluation was conducted using the cylinder-plate method. NCCP 16830 presented valid results and had the same performance as ATCC 6538P; therefore, it was selected as an alternative candidate strain.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Data Availability Statement
The data used in this study are available in this article.
References
Buck, M. and Hamilton, C. 2011. The Nagoya Protocol on access to genetic resources and the fair and equitable sharing of benefits arising from their utilization to the convention on biological diversity. Rev. Eur. Comp. Int. Environ. Law 20, 47–61.
Chun, J., Lee, J.H., Jung, Y., Kim, M., Kim, S., Kim, B.K., and Lim, Y.W. 2007. EzTaxon: a web-based tool for the identification of prokaryotes based on 16S ribosomal RNA gene sequences. Int. J. Syst. Evol. Microbiol. 57, 2259–2261.
CLSI, Clinical and Laboratory Standards Institute. 2019. Performance Standards for Antimicrobial Susceptibility Testing. 29th edn, pp. 34–44. CLSI supplement M100. Wayne, Pennsylvania, USA.
Connolly, P., Bloomfield, S.F., and Denyer, S.P. 1994. The use of impedance for preservative efficacy testing of pharmaceuticals and cosmetic products. J. Appl. Bacteriol. 76, 68–74.
Darling, A.C.E., Mau, B., Blattner, F.R., and Perna, N.T. 2004. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 14, 1394–1403.
Delmas, J., Chacornac, J.P., Robin, F., Giammarinaro, P., Talon, R., and Bonnet, R. 2008. Evaluation of the Vitek 2 system with a variety of Staphylococcus species. J. Clin. Microbiol. 46, 311–313.
Enright, M.C., Day, N.P., Davies, C.E., Peacock, S.J., and Spratt, B.G. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38, 1008–1015.
Lane, D.J. 1991. 16S/23S rRNA sequencing. In Stackebrandt, E. and Goodfellow, M. (eds.), Nucleic Acid Techniques in Bacterial Systematic, pp. 115–175. John Wiley & Sons, New York, USA.
Lee, I., Kim, Y.O., Park, S.C., and Chun, J. 2016. OrthoANI: An improved algorithm and software for calculating average nucleotide identity. Int. J. Syst. Evol. Microbiol. 66, 1100–1103.
MFDS, Ministry of Food and Drug Safety. 2014. The Korean Pharmacopoeia, 11th edn., pp. 2095–2392. Ministry of Food and Drug Safety, Republic of Korea.
Oh, H.Y., Kim, D.S., Kim, Y.O., Yoo, M.Y., Lee, S., Sohn, K.H., Um, S.Y., Kim, D.H., Kim, T.S., and Oh, I.U. 2009. Introduction of worldwide organizations and systems of Pharmacopoeia. Regul. Res. Food Drug Cosmet. 4, 29–38.
Singhal, N., Kumar, M., Kanaujia, P.K., and Virdi, J.S. 2015. MALDITOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front. Microbiol. 6, 791.
United States Pharmacopeia. 2020. Antibiotics-Microbial Assays, USP43-NF38 — 6488, pp. 44. The Unites States Pharmacopoeia, Maryland, USA.
Acknowledgements
This study was funded by the Korea Disease Control & Prevention Agency, Ministry of Health and Welfare, grant numbers 2017-NG45005-00 and 2019-NG-047-00.
Author information
Authors and Affiliations
Contributions
Conceptualization, S.Y.K.; methodology, Y.W.A.; software, Y.W.A.; validation, S.Y.K., Y.W.A., Y.S.C., M.Y., and C.C.; formal analysis, S.Y.K.; investigation, S.Y.K., Y.W.A., and Y.S.C.; resources, S.Y.K.; data curation, Y.W.A.; writing-original draft preparation, Y.W.A.; writing-review and editing, S.Y.K.; visualization, Y.W.A.; supervision, S.Y.K. and Y.S.C.; project administration, S.Y.K. and Y.W.A.; funding acquisition, S.Y.K. and Y.S.C. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
The authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
An, Y.W., Choi, Y.S., Yun, Mr. et al. Characterization and validation of an alternative reference bacterium Korean Pharmacopoeia Staphylococcus aureus strain. J Microbiol. 60, 187–191 (2022). https://doi.org/10.1007/s12275-022-1335-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-022-1335-5